Tue, 19 Nov 2019 13:40:12: Myovant's oral prostate cancer drug matches incumbent in phase 3

Tue, 19 Nov 2019 11:53:33: Novartis tight-lipped on MedCo buyout rumors

Tue, 19 Nov 2019 10:26:38: Novo Ventures, Broad Institute form drug discovery pact

Tue, 19 Nov 2019 08:39:30: FDA to AstraZeneca to small biotech: Badrul Chowdhury on the move again

Mon, 18 Nov 2019 14:00:52: Struggling Alkermes spends $950M sculpting Rodin buyout

Mon, 18 Nov 2019 13:14:27: Bayer, Merck's vericiguat hits endpoint in heart failure phase 3

Mon, 18 Nov 2019 09:50:27: AHA: MedCo's PCSK9 rival inclisiran hits LDL

Mon, 18 Nov 2019 08:54:48: AHA: Analysis counters concerns about Amgen heart failure drug

Mon, 18 Nov 2019 08:24:10: AHA: Caladrius single injection helps heart disease that hits women the hardest

Fri, 15 Nov 2019 13:38:27: Arrowhead R&D lead steps down, biotech vets step in

Fri, 15 Nov 2019 13:26:46: EpicentRx raises $35M to fund late-phase lung cancer trial

Fri, 15 Nov 2019 13:09:53: After BMS said no, Roche puts $1.4B on the table for Promedior, boosting fibrotic pipeline

Fri, 15 Nov 2019 12:48:24: Sarepta pays StrideBio $48M for preclinical gene therapies

Thu, 14 Nov 2019 17:39:44: Chutes & Ladders—Abbott CEO White out after 21 years on the job

Thu, 14 Nov 2019 14:18:37: ATAI Life Sciences, Cyclica team up for mental health JV

Thu, 14 Nov 2019 13:47:04: VistaGen fails phase 2 depression trial, sparking stock rout

Thu, 14 Nov 2019 09:00:39: Allergan pays Exicure $25M to discover nucleic acid hair loss drugs

Wed, 13 Nov 2019 20:46:44: Could this immuno-oncology combo treat metastatic prostate cancer?

Wed, 13 Nov 2019 16:18:36: Genfit CEO Pascal Prigent on better NASH tests for R&D and the doctor's office

Wed, 13 Nov 2019 14:21:45: Halting the progression of multiple sclerosis by blocking harmful B cells

Wed, 13 Nov 2019 13:33:42: Kiadis dumps phase 3 drug, halves head count in pivot to NK cells

Wed, 13 Nov 2019 11:57:02: Stanford researchers pursue AnaptysBio's embattled IL-33 drug in peanut allergy

Wed, 13 Nov 2019 09:56:05: Weill Family Foundation gifts $106M for public-private 'Neurohub'

Wed, 13 Nov 2019 09:23:57: Merck buys Calporta for preclinical neurodegeneration assets

Wed, 13 Nov 2019 08:25:34: Merck to slash more than 100 R&D jobs from French site